INTRODUCTION
C-X-C chemokines, cytokine-induced neutrophil chemoattractant-1 (CINC-1) and macrophage inflammatory protein-2 (MIP-2), have been identified and these chemokines appear to be critical mediators of neutrophil recruitment into tissues. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Inducers of C-X-C chemokine production in vitro have been described including lipopolysaccharide (LPS), tumor necrosis factor-a (TNF-a), thrombin, platelet-derived growth factor, and complement. 5, 6, [12] [13] [14] [15] [16] [17] IL-1 is a potent stimulator of IL-8 production in vitro from human fibroblasts, monocytes, hepatocytes and endothelial cells. 7, 13, 15, 16, 18 IL-1 given intratracheally to the rat results in the production of CINC-1 and the recruitment of neutrophils to the lung. 19, 20 However, the role of endogenous IL-1 on tissue chemokine production and neutrophil recruitment following LPS has not been fully elucidated. Inhibition of IL-1 bioactivity in various inflammatory diseases results in a decrease in the number of infiltrating neutrophils associated with local inflammation. Interestingly, IL-1 itself is not a chemoattractant for neutrophils. 21, 22 It is likely that IL-1 mediates neutrophil recruitment through IL-1-induced synthesis of IL-8 and other related C-X-C chemokines. The purpose of the present study was to determine the effect of reduction of biological activity of IL-1 on C-X-C chemokine production and PMN accumulation in the lung and liver following LPS. We hypothesized that IL-1 regulates LPS induced CINC-1 and MIP-2 production and subsequent neutrophil sequestration.
MATERIALS AND METHODS

Reagents
Recombinant human IL-1Ra was kindly supplied by Amgen, Inc. (Thousand Oaks, CA, USA). Chemicals and other reagents, unless otherwise stated, were obtained from Sigma Chemical Co. (St Louis, MO, USA).
Animal model of endotoxemia
Male Sprague-Dawley rats (250-300 g) were used for all studies. Animals were quarantined for 2 weeks prior to use in experiments. Animals received 500 mg/kg LPS (Salmonella typhimurium) by intraperitoneal (i.p.) injection or vehicle (sterile saline) with and without IL-1Ra. IL-1Ra (10 mg/kg) was given 5 min prior to LPS. Animals were anesthetized with pentobarbital (50 mg/kg, i.p.) at 1, 2, 4, 6, 8, or 12 h after LPS. Blood was harvested in a heparinized syringe, centrifuged at 1000 g and the plasma fraction collected and frozen at -70°C for later analysis. Organs were removed, blotted dry, weighed, snap frozen in liquid nitrogen, and stored at -70°C prior to analysis.
Myeloperoxidase (MPO) assay
Neutrophil accumulation was assessed by MPO activity using an assay as previously described. 23 A segment (300-400 mg) of tissue was homogenized for 30 s in 4 ml of 20 mM potassium phosphate buffer (pH 7.4) and then centrifuged for 30 min at 40,000 g at 4°C (Beckman L-80 Ultracentrifuge, Beckman Instruments, Palo Alto, CA, USA). An aliquot of the supernatant was saved for ELISA assays. The pellet was resuspended in 4 ml of 50 mM potassium phosphate buffer (pH 6.0) containing 5 g/dl of cetrimonium bromide. The samples were then sonicated on ice for 90 s at full power (Ultrasonic homogenizer, Cole-Parmer Instrument Co., Chicago, IL, USA), incubated at 60°C for 2 h, and centrifuged for 10 min at maximum speed (Eppendorf 5415C, Baxter, San Diego, CA, USA). The supernatant (25 ml) was added to 725 ml of 50 mM phosphate buffer (pH 6.0) containing 0.167 mg/ml of o-dianisidine and 0.0001% hydrogen peroxide. Absorbancy at 460 nm (DA460) was measured 1-3 min after the initiation of the reaction (Beckman DU7 spectrophotometer, Beckman Instruments, Irvine, CA, USA). MPO activity/g of wet tissue was then calculated as: MPO activity (units/g wet tissue) = (DA460 ´13.5)/sample weight (g). The coefficient 13.5 was empirically determined such that 1 unit of MPO activity is the amount of enzyme that will reduce 1 mmole of peroxide/min. 24 
Cytokine and chemokine ELISA
Cytokine and chemokine protein levels were determined by ELISA. The rat CINC-1 ELISA kit was obtained from Immuno-Biological Laboratories, Co. (Fujioka-City, Japan). The rat IL-1b and MIP-2 kits were obtained from BioSource International, Inc. (Camarillo, CA, USA). Absorbency of standards and samples were determined spectrophotometrically using a microplate reader (Bio-Rad Laboratories, Hercules, CA, USA). Results were recorded as optical densities and plotted against the linear portion of the standard curve.
Northern blot analysis
Northern blotting was performed as described by Henderson and colleagues. 25 Lung and liver tissue was homogenized with a tissue homogenizer (Virtishear homogenizer; Virtis, Gardner, NY, USA) in 10 volumes of TRI Reagent (Molecular Research Center, Cincinnati, OH, USA). Total RNA was extracted using the guanidium-isothiocyanate method. 26 Quantification of RNA was performed spectrophotometrically by reading the absorbancy at 260 nm. Total RNA (12 mg) from each sample was denatured and electrophoresed on a 1.2% agarose/6.6% formaldehyde gel containing 10 mg/ml ethidium bromide. Gels were soaked in 10x SSPE (0.1 M sodium phosphate [pH 7.0], 1.5 M sodium chloride, 0.02 M EDTA) for 1 h prior to overnight capillary transfer (GibcoBRL Life Technologies, Gaithersburg, MD, USA) in 10x SSPE onto a nylon membrane (Stratagene, La Jolla, CA, USA). Following transfer, the membrane was UV cross-linked with a UV Stratalinker (Stratagene) and ribosomal RNA visualized and photographed under UV light to assess RNA loading. Membranes were then wet with 2x SSPE and placed in a Mini-6 hybridization oven (Hybaid, Franklin, MA, USA). All prehybridization, hybridization, and high stringency wash temperatures were calculated based on a previously published method. 22 The hybridization solution consisted of: 1´SSPE, 2´Denhardt's solution, 1% non-fat dry milk, 10% dextran sulfate, 2% SDS, 200 mg/ml salmon sperm DNA, 200 mg/ml yeast tRNA, and 200 mg/ml polyadenylic acid. Prehybridization was carried out at the probe-appropriate temperature for 8-12 h. The prehybridization solution was then decanted and 10 ml of hybridization solution containing labeled probes at 5.0 x 10 6 cpm/ml added and incubated for approximately 18 h. Both CINC-1 and MIP-2 probes were single stranded 30-mer DNA oligonucleotides synthesized by Gibco-BRL/Life Technologies. The CINC-1 probe has the sequence 5¢-GCG-GCATCACCTTCACTCTGGATGTTCT-3¢, and is complementary to nucleotides 170-199 of the rat CINC-1 cDNA. 14 The MIP-2 probe has the sequence 5¢-GTTAGCCTTGC-CTTTGTTCAGTATCTTTTG-3¢ and is complementary to rat MIP-2 cDNA nucleotides 304-333. Oligonucleotide probes were labeled by terminal deoxynucleotidyl transferase (TdT; Gibco-BRL, Rockville, MD, USA). The labeling reaction was carried out by adding 2 ml of a 10 ng/ml solution of oligonucleotide, 2 ml of 1 mg/ml bovine serum albumin, 4 ml 5x TdT buffer (GIBCO BRL), 10 ml (33 pmol) [a-32 P]-dATP (Du Pont NEN, Boston, MA, USA), and 2 ml of 15 U/ml recombinant TdT (GIBCO BRL). The reaction was incubated for 1 h at 37°C. Unincorporated nucleotide was removed by a NucTrap probe purification column (Stratagene, La Jolla, CA, USA).
Following hybridization, blots were then washed in 1x SSPE buffer containing 0.5% SDS and 0.1% non-fat dry milk at room temperature. A second set of washes were carried out in 0.2x SSPE with 1% SDS at room temperature. A final, high stringency wash was done in 0.1x SSPE with 0.5% SDS at the calculated temperature. The membrane was then dried, covered in plastic wrap, and exposed to X-ray film (BioMax-1 MR-1, Kodak) in the presence of two intensifying screens at -70°C. Quantification of specific mRNA species was accomplished by densitometry (NIH application 1.599b4) and normalized to 28S rRNA. Membranes were stripped with 2 mM EDTA (pH 8.0), 2 mM Tris (pH 8.0), and 10x Denhardt's solution for 2 and 3 h at 65°C. Membranes were then reprobed as indicated.
Plasma aspartate aminotransferase (AST)
Plasma AST was measured using the coupled enzymatic rate assay (Roche Laboratories, Indianapolis, IN, USA) and reported as U/ml of plasma.
Lung maldonaldehyde (MDA) assay
Levels of MDA in the lung were determined as an index of lipid peroxidation. 27 Lung was harvested at the specified time, washed with normal saline, blotted dry, and immediately snap frozen in liquid nitrogen. Samples were stored at -70°C until the assay was performed. For the MDA assay, lung tissue was homogenized in 5% w/v 1.15% KCl solution. A 100 ml aliquot of the homogenate was added to the reaction mixture, which contained 100 ml 8.1% SDS, 750 ml 20% acetic acid (pH 3.5), 750 ml 0.8% thiobarbituric acid, and 350 ml deionized H 2 O. Samples were then boiled for 1 h at 95°C and centrifuged at 3000 g for 15 min. The absorbance of the supernatant was measured by spectrophotometry at 655 nm.
Statistical analysis
Data are presented as mean -SEM. Analysis of variance (ANOVA) with a post-hoc Bonferoni-Dunn test was performed to analyze differences between experimental IL-1 regulates in vivo C-X-C chemokine induction and neutrophil sequestration following endotoxemia 61 groups using Statview 4.0 (Brain Power; Calabasas, CA, USA).
RESULTS
Effects of LPS on in vivo IL-1b and chemokine induction
Studies were performed to determine the effect of S. typhimurium LPS on plasma and tissue (lung and liver) levels of IL-1b and chemokine induction. Initial studies revealed a time-dependent induction of IL-1b, CINC-1 and MIP-2 protein in plasma and tissue. For IL-1b, plasma levels increased 200-fold by 4 h, and returned to baseline 8 h following LPS (Fig. 1A) . For the chemo-kines, LPS administration resulted in a steady increase in both plasma CINC-1 and MIP-2 for 1-12 h ( Fig. 1B) . At the end of this period, these chemokines continued to rise in the circulation.
Lung and liver homogenates were then examined to determine the tissue-specific time course for LPS induction of both IL-1b and the C-X-C chemokines. Although we detected a small amount of resting IL-1b in the liver, this rose 3-fold when compared to vehicle-injected rats 6 h following LPS ( Fig. 2A) . In the lung, the peak in IL-1b occurred within 2 h following LPS and slowly declined toward control levels within 12 h ( Fig. 2A) . Tissue levels of both CINC-1 and MIP-2 were undetectable at baseline. Within 2 h, CINC-1 levels were higher than baseline in both lung and liver and began to peak 8 h following LPS (Fig. 2B) . One hour after LPS, MIP-2 in 62 Calkins, Bensard, Shames, Pulido, Abraham, Fernandez et al. both lung and liver increased 4-fold from baseline and reached peak levels 6-8 h later (Fig. 2C) .
Role of IL-1Ra on IL-1 and chemokine protein production
We next evaluated the role of IL-1 in LPS-induced C-X-C chemokine induction. Rats were injected with human IL-1Ra (10 mg/kg) prior to LPS. This dose is similar to that used in other rodent studies 28, 29 and has no agonist activity. 30 Because there is little species specificity, human IL-1Ra can be used in rodents and other species. 31 Given the time course data described above, a 6 h time point was used to evaluate the role of IL-1Ra on IL-1b and chemokine production. IL-1Ra given 5 min prior to LPS exhibited a 41% decrease (P < 0.05) in circulating IL-1b, a 100% decrease (P < 0.05) in MIP-2, and no change in circulating CINC-1 compared to LPS-treated controls (Fig. 3 ). As shown in Figure 4 , IL-1Ra pretreatment blunted the LPS-induced increase in both lung and liver tissue IL-1b ( Fig. 4A,B ). There was a 45% decrease in CINC-1 in the liver (P < 0.05), and a 6% decrease in the lung. On the other hand, IL-1Ra pretreatment resulted in a 72% and 100% decrease in lung and liver MIP-2 protein, respectively, after LPS (Fig. 4A,B) .
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Effect of IL-1 on chemokine mRNA production following LPS
To determine if the effect of IL-1Ra on chemokine protein production is also at the level of gene expression, steadystate mRNA levels in rat lung and liver tissue were examined 6 h following LPS for the presence of CINC-1 (Fig.  5A ) and MIP-2 (Fig. 5B ) mRNA using Northern blot analysis. LPS induced an increase in the levels of CINC-1 and MIP-2 transcripts in both lung and liver. IL-1Ra given 5 min prior to LPS resulted in a 20% decrease in CINC-1 mRNA in the liver, but not in the lung. MIP-2 mRNA levels in both liver and lung were decreased (50% and 62%, respectively) by IL-1Ra treatment prior to LPS. These results suggest that LPS-induced gene expression for CINC-1 and MIP-2 are regulated by IL-1, yet the absence of an effect of IL-1Ra on lung CINC-1 suggests the production of this chemokine in the lung is largely IL-1 independent.
Effects of IL-1 on LPS-induced neutrophil sequestration
To determine the role of IL-1 on neutrophil sequestration within the lung and liver, MPO activity in both organs was measured 6 h following saline, LPS, or IL-1Ra+LPS. Blockade of IL-1 receptors with pretreatment by IL-1Ra resulted in a 47% and 59% decrease in both lung (Fig. 6A ) and liver (Fig. 6B) neutrophil accumulation, respectively, following LPS (P < 0.05 compared to LPS treated animals).
Effect of IL-1 on lung lipid peroxidation and hepatocellular injury following LPS
To determine the role of IL-1 on tissue injury in the lung following LPS, lipid peroxidation was quantified in lung tissue by measuring the activity of maldonaldehyde (MDA) 24 h following LPS. IL-1Ra pretreatment resulted in a 60% reduction in lung lipid peroxidation when compared to LPS-treated animals (Fig. 7A) . To determine the effect of IL-1 on tissue injury in the liver following LPS, hepatocellular damage was quantified by measurement of plasma AST levels 24 h following LPS. IL-1Ra pretreatment resulted in a 100% reduction in plasma AST when compared to LPS treated animals ( Fig. 7B ).
DISCUSSION
We found that LPS induced a rapid increase in plasma IL-1b that reaches peak levels at 4 h. This increase in IL-1b is associated with an increase in plasma CINC-1 and MIP-2 by 1 h, which is sustained for 12 h. Similarly, there is an increase in lung and liver expression of IL-1b and the C-X-C chemokines CINC-1 and MIP-2 associated with 64 Calkins, Bensard, Shames, Pulido, Abraham, Fernandez et al. an increase in neutrophil accumulation in both organs. IL-1Ra reduced the increase in IL-1b in the plasma, lung, and liver. IL-1Ra pretreatment prevented the increase in MIP-2 in plasma, lung and liver as well as CINC-1 in the liver, but IL-1 blockade had little effect on CINC-1 in the plasma or lung. IL-1Ra pretreatment also resulted in decreased neutrophil accumulation in the lung and liver as well as attenuated tissue injury as assessed by lung lipid peroxidation (MDA) and AST levels. Thus, endogenous IL-1 mediates tissue neutrophil recruitment in the lung and liver. In addition, IL-1 regulates further IL-1b production and expression of MIP-2. However, there are other factors that regulate expression of CINC-1 in the lung. In this study, IL-1Ra inhibited the increase in IL-1b seen in the plasma, liver and lung after LPS. IL-1 is well known to induce further IL-1 production and previous investigations have reported that IL-1Ra inhibits IL-1 production via downregulation of steady-state levels of IL-1 transcripts. 32, 33 A decrease in IL-1 levels due to IL-1Ra could be one cause of a decrease in chemokine expression. Inhibition of IL-1 production with IL-1Ra caused a decrease in MIP-2 mRNA induction and protein expression in both tested organs, but it did not affect CINC-1 expression in the lung. Clearly, factors other than IL-1 contribute to chemokine regulation following LPS. Specifically, LPS itself may have directly stimulated chemokine production through activation of the Toll-like receptor-4 (TLR-4). In addition, although we utilized S. typhi LPS in this study, LPS from other species of bacteria may activate TLR-4 or other combinations of Toll-like receptors to invoke a cytokine response different from that of S. typhi LPS. Alternatively, bacterial lipoprotein contaminants in commercially available LPS may afford signaling through Toll-like receptor-2. 34 In addition, LPS can lead to the production of TNF-a and C5a, which can subsequently stimulate production of chemokines in a model of lung inflammation caused by immune complex deposition. 12 Interestingly, inhibition of either TNF-a or C5a alone resulted in a 60% decrease in chemokine generation. Other potential stimulators of chemokine expression include thrombin and platelet-derived growth factor. 14, 17 The wide range of IL-1 effects may be due to induction of genes or increased synthesis of proteins. 31 IL-1Ra may inhibit chemokine gene expression directly or via inhibition of gene expression of other cytokines such as IL-1 itself, TNF-a, or IL-6. In addition, chemokine gene expression may be affected by IL-1-induced cyclooxygenase type 2, inducible nitric oxide synthetase, phospholipase A 2 or complement. The transcription of multiple chemokine genes, including IL-8, CINC-1 and MIP-2, are regulated by the transcription factors nuclear factor kappa B (NF-kB) and activating protein-1 (AP-1). [35] [36] [37] [38] Thus IL-1Ra may inhibit CINC-1 and MIP-2 gene expression via inhibition of IL-1-induced activation of NF-kB or AP-1. Alternatively, IL-1 is capable of stabilization of chemokine mRNA with an increase in mRNA halflife. 37 Therefore, IL-1Ra treatment may result in a decrease in steady-state CINC-1 and MIP-2 transcripts by preventing IL-1 induced stabilization of mRNA.
IL-1Ra inhibits the bioactivity of both IL-1a and IL-1b. 31 Therefore, the current data do not allow us to determine which isoform of IL-1 is mediating chemokine induction and neutrophil sequestration. IL-1b deficient mice respond to systemic LPS similarly to wild-type mice in that they produce comparable amounts of circulating cytokines (IL-1a, IL-6, or TNF-a). However, some models of local inflammation, such as turpentine-induced tissue damage, do not develop an acute-phase response. 39, 40 Furthermore, IL-1b deficient mice are not protected from lung neutrophil migration when subjected to hemorrhagic shock. 41 In most situations, IL-1b is a systemic, hormone-like mediator and IL-1a acts in an autocrine or paracrine fashion. 31 Studies to determine the effect of IL-1a have used IL-1Ra in IL-1b deficient mice. In one study, IL-1b deficient mice exhibited decreased zymosan-induced lethality, peritoneal cellular infiltrate, and reduced production of IL-1a and IL-6 compared with wildtype controls. 42 However, there was no further inhibitory effect of IL-1Ra on IL-6 production in IL-1b deficient mice, suggesting no role for IL-1a in zymosan-induced IL-6 production. In one in vitro study using membrane bound IL-1 on LPS-stimulated peripheral blood mononuclear cells, endothelial cell and fibroblast production of IL-8 was blocked by IL-1Ra. 15 The present findings further support studies suggesting CINC-1 and MIP-2 production are required for lung and liver neutrophil sequestration. Several investigators have used CINC and MIP-2 antiserum or antibodies to determine their roles in models of tissue injury. 8, 11, 20, 36, [43] [44] [45] In the IgG immune complex-induced model of acute lung injury, specific blockade of either MIP-2 or CINC significantly reduced lung injury and reduced neutrophil accumulation. 11 Intratracheal injection of antiserum to CINC inhibits intratracheal LPS and IL-1 induced neutrophil emigration into BAL fluid by approximately 60-70%. 44 In a lung injury model due to intratracheal IL-1, anti-CINC antibody decreased lung lavage neutrophil numbers and lung leak. However, this anti-CINC antibody failed to inhibit lung neutrophil accumulation as assessed by MPO assay. 20 Administration of intratracheal CINC alone fails to induce lung injury or neutrophil accumulation in a cecal ligation and puncture model of peritonitis. 20 Inhibition of keratinocyte-derived chemokine (KC) had no effect on overall neutrophil sequestration in liver, but reduced injury as measured by serum transaminases; however, inhibition of MIP-2 reduced both lung neutrophil sequestration and peritoneal neutrophil migration. 8
CONCLUSIONS
We found that IL-1Ra decreases LPS-induced IL-1b production and MIP-2 expression in the lung and liver. Furthermore, IL-1Ra inhibited expression of CINC-1 in the liver but not the lung. Despite the lack of an effect of IL-1Ra on lung CINC-1 levels, IL-1Ra attenuated lung neutrophil accumulation in both lung and liver after LPS. These data suggest that IL-1 regulates tissue chemokine expression and neutrophil accumulation after LPS. However, factors other than CINC-1 contribute to neutrophil accumulation in the lung.
